The Detection of Novel Nitazene‐Class Opioids in Unregulated Drug Markets in Canada.
| Published in: | Drug & Alcohol Review Vol. 45; no. 5; pp. 1 - 13 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
Wiley-Blackwell
Jul2026
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195655169&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 195655169 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09595236 57J jtl: Drug & Alcohol Review issn: 09595236 maglogo: Y pubinfo: dt: Jul2026 vid: 45 iid: 5 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 195655169 10.1111/dar.70189 195655169 ppf: 1 ppct: 12 formats: tig: atl: The Detection of Novel Nitazene‐Class Opioids in Unregulated Drug Markets in Canada. aug: au: Gelgoot, Emily A. Scarfone, Kristy M. Maghsoudi, Nazlee McDonald, Karen Hao, Wenqing Stefan, Cristiana Beriault, Daniel R. Delaney, Sarah R. Ti, Lianping Tobias, Samuel Bowles, Jeanette M. Werb, Dan affil: Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|